Free Submission Public Relations &
Deutsch English


Sigma-Tau Pharmaceuticals, Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile - New Report Available

Print article Print article
2014-04-07 08:26:26 - Fast Market Research recommends "Sigma-Tau Pharmaceuticals, Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile" from GlobalData, now available

Sigma-Tau Pharmaceuticals, Inc. (Sigma-Tau) is a research based biotechnology company that focuses on discovering and developing novel medicines to treat rare diseases. It product portfolio comprises prescription products and consumer products. Sigma-Tau's prescription products include Adagen (pegademase bovine), Matulane (procarbazine hydrochloride), Carnitor (levocarnitine), Oncaspar (pegaspargase), Depocyt (Cytarabine Liposome Injection) and Abelcet (amphotericin B lipid complex injection). The company through its consumer product segment produces non-prescription medicines and dietary supplements, which include Proxeed Plus, a male fertility supplement and vsl#3, a medical probiotic food for patients with, irritable bowel syndrome and ulcerative colitis (UC). Its research pipeline comprises three NDA candidates including Defibrotide for the treatment of Hepatic venous, Nuartez (artesunate) injection, for the treatment of severe malaria and Xenbilox (chenodeoxycholic

acid) capsules treatment of cerebrotendinous xanthomatosis; EZN-2279 is in Phase III development for enzyme replacement therapy for adenosine deaminase (ADA) deficiency in patients with severe combined immunodeficiency disease; STP-206 live biotherapeutic is in Phase II development for prevention of necrotizing enterocolitis (NEC); EZN-2285 for which biologics license application (BLA) is indicated for the prevention of necrotizing enterocolitis (NEC). It operates as subsidiary of Sigma-Tau S.p.A. Sigma-Tau is headquartered in Gaithersburg, Maryland, the US.

Full Report Details at
- ..

Sigma-Tau Pharmaceuticals, Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.


* Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
* Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
* Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
* Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
* Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
* Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
* Business Description - A brief description of the company's operations.
* Key Employees - A list of the key executives of the company.
* Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
* Key Competitors - A list of the key competitors of the company.
* Key Recent Developments - A brief on recent news about the company.

Reasons to Get this Report

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

* The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

* The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

* Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

* The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

* Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

* Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Companies Mentioned in this Report: Sigma-Tau Pharmaceuticals, Inc

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Bill Thompson
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact